Nova Leap Health Corp.
NVLPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3% | 13.1% | 7.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.6% | 40.2% | 39% | 39.1% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 10.9% | -3.3% | 2.8% | 19.4% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 5.2% | -6% | -1.1% | 13.5% |
| EPS Diluted | 0.005 | -0.006 | -0.001 | 0.01 |
| % Growth | 187.3% | -450% | -109.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |